Veytics Intelligence
2026-10-13 · NASDAQ

Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsBristol Myers Squibb offers a significant yield and recovery in net income, supported by its strong oncology and cardiovascular segments.

Ler o briefing completo da Veytics

Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.